← All news
Tech
Cambridge Cognition (LSE:COG) joins a dementia diagnosis push this week: where does digital testing fit in AI-era healthcare?

Highlights Cambridge Cognition launched a UK Alzheimer's diagnosis pathway with C2N Diagnostics and The Alzheimer's Trust. The pathway combines a blood test, the CANTAB Pathway digital assessment and access to scans. Interim results showed…
Covered by 1 outlet
All coverage · 1 article